TAILIEUCHUNG - Hepatitis C and kidney disease: A narrative review

Hepatitis-C (HCV) infection can induce kidney injury, mostly due to formation of immunecomplexes and cryoglobulins, and possibly to a direct cytopathic effect. It may cause acute kidney injury (AKI) as a part of systemic vasculitis, and augments the risk of AKI due to other etiologies. It is responsible for mesangiocapillary or membranous glomerulonephritis, and accelerates the progression of chronic kidney disease due to other causes. HCV infection increases cardiovascular and liver-related mortality in patients on regular dialysis. HCV-infected patients are at increased risk of acute post-transplant complications. Long-term graft survival is compromised by recurrent or de novo glomerulonephritis, or chronic transplant glomerulopathy. Patient survival is challenged by increased incidence of diabetes, sepsis, post-transplant lymphoproliferative disease, and liver failure. Effective and safe directly acting antiviral agents (DAAs) are currently available for treatment at different stages of kidney disease. However, the relative shortage of DAAs in countries where HCV is highly endemic imposes a need for treatmentprioritization, for which a scoring system is proposed in this review. It is concluded that the thoughtful use of DAAs, will result in a significant change in the epidemiology and clinical profiles of kidney disease, as well as improvement of dialysis and transplant outcomes, in endemic areas. | Journal of Advanced Research 2017 8 113-130 Cairo University Journal of Advanced Research REVIEW Hepatitis C and kidney disease A narrative review CrossMark Rashad S. Barsoum a b Emad A. Williamb c Soha S. Khalilb aKasr-El-Aini Medical School Cairo University Cairo Egypt b The Cairo Kidney Center Cairo Egypt c National Research Centre Cairo Egypt GRAPHICAL ABSTRACT failure Cardiovascular events Autoimmunity v Direct Cytotoxic Cryoglobulins Ị . A . 1 Glomerulonephritis Acute graft injury Chronic Tx glomerulopathy De-novo recurrent GN sepsis NODAT PTLD Liver failure ARTICLE INFO ABSTRACT Article history Received 19 April 2016 Received in revised form 7 July 2016 Accepted 17 July 2016 Available online 26 July 2016 Keywords Acute kidney injury Chronic kidney disease Glomerulonephritis Hepatitis-C HCV infection can induce kidney injury mostly due to formation of immune-complexes and cryoglobulins and possibly to a direct cytopathic effect. It may cause acute kidney injury AKI as a part of systemic vasculitis and augments the risk of AKI due to other etiologies. It is responsible for mesangiocapillary or membranous glomerulonephritis and accelerates the progression of chronic kidney disease due to other causes. HCV infection increases cardiovascular and liver-related mortality in patients on regular dialysis. HCV-infected patients are at increased risk of acute post-transplant complications. Long-term graft survival is compromised by recurrent or de novo glomerulonephritis or chronic transplant glomerulopathy. Patient survival is challenged by increased incidence of diabetes sepsis post-transplant lymphoproliferative disease and liver failure. Effective and safe directly acting antiviral agents DAAs Corresponding author. Fax 20 225790267. E-mail address . Barsoum . Peer review under responsibility of Cairo University. Production and hosting by Elsevier http 2090-1232 2016 Production and hosting by Elsevier

• Y khoa - Dược
• Acute kidney injury
• Chronic kidney disease
• Hepatitis C
• Kidney disease
• HCV is highly endemic imposes
• Contrast nephropathy
• Heat stress nephropathy
• Serum uric acid
• BMC Anesthesiology
• Contrast associated acute kidney injury
• Intensive care unit
• RIFLE classification
• End stage kidney diseas
• BMC Pediatrics
• Idiopathic renal hypouricemia
• Gene mutation
• Exercise induced acute kidney injury
• Re absorption insufficiency
• Acute nephrology for the critical care physician
• AKI Defi nitions and clinical context
• Epidemiology of AKI
• Renal outcomes after acute kidney injury
• Pathophysiology of acute kidney injury
• Kidney organ interaction
• Acute nephrology
• The critical care physician
• Acute kidney injury biomarkers
• Prevention and protection
• Renal replacement therapy
• Acute coronary syndrome
• Percutaneous coronary intervention
• Prediction model
• Intra aortic balloon pump
• BMC Pharmacology and Toxicology
• Acute colchicine intoxication
• Continuous renal replacement therapy
• Acute toxicosis
• BMC Cancer
• Adverse effect
• Renal cell carcinoma
• Everolimus treatment
• 3 methyladenine
• LPS induced kidney injury
• Systemic inflammatory
• Poor clinical outcomes
• Intracellular proteolytic system
• Elderly patients
• Renal injury
• Risk score
• BMC Pulmonary Medicine
• Coronavirus disease 2019
• Acute respiratory distres
• Mechanical ventilation
• Community acquired pneumonia
• Angiotensin receptor blocker
• Acute respiratory failure
• Radical nephrectomy
• Inferior vena cava thrombectomy
• Myocardial injury
• trình bày báo cáo
• tài liệu báo cáo khoa học
• nghiên cứu y học
• báo cáo y học
• kiến thức y học
• công trình y học
• Radical cystectomy
• Uric acid
• Including AKI
• Risk factors of AKI
• Glycopeptide antibiotic
• Neonatal intensive care unit
• Serum creatinine
• Critically ill children
• Cystatin C
• Fibroblast growth factor 23
• Insulin like growth factor binding protein 7
• Pediatric risk of mortality III score
• Locally advanced squamous cell carcinoma
• High dose cisplatin
• Risk factors
• BMC Musculoskeletal Disorders
• Femoral neck fractures
• Intraoperative hypotension
• Myocardial infarction
• Clinical practice research datalink
• Lower respiratory tract infection
• Non cystic fibrosis bronchiectasis
• Partial nephrectomy
• Hemodynamic management
• Compromise renal function
• Insulin like growth factor binding proteins
• Tissue inhibitor of Metalloproteinase 2
• Cardiac surgical procedures